Machina Capital S.A.S. raised its stake in shares of Colgate-Palmolive Company (NYSE:CL – Free Report) by 179.1% in the 3rd quarter, Holdings Channel reports. The firm owned 91,754 shares of the company’s stock after purchasing an additional 58,882 shares during the quarter. Colgate-Palmolive accounts for 1.0% of Machina Capital S.A.S.’s investment portfolio, making the stock its 7th largest holding. Machina Capital S.A.S.’s holdings in Colgate-Palmolive were worth $7,828,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. Silver Grove Financial Group Inc. lifted its holdings in Colgate-Palmolive by 22.1% in the third quarter. Silver Grove Financial Group Inc. now owns 988 shares of the company’s stock valued at $84,000 after buying an additional 179 shares during the period. Illinois Municipal Retirement Fund boosted its stake in Colgate-Palmolive by 32.9% during the third quarter. Illinois Municipal Retirement Fund now owns 304,117 shares of the company’s stock worth $25,947,000 after acquiring an additional 75,365 shares in the last quarter. New York Life Investment Management LLC boosted its stake in Colgate-Palmolive by 1.5% during the third quarter. New York Life Investment Management LLC now owns 138,465 shares of the company’s stock worth $11,814,000 after acquiring an additional 1,988 shares in the last quarter. 71 West Capital Partners grew its holdings in Colgate-Palmolive by 34.8% in the third quarter. 71 West Capital Partners now owns 6,802 shares of the company’s stock worth $580,000 after purchasing an additional 1,755 shares during the period. Finally, AEGON ASSET MANAGEMENT UK Plc grew its holdings in Colgate-Palmolive by 19.8% in the third quarter. AEGON ASSET MANAGEMENT UK Plc now owns 863,616 shares of the company’s stock worth $73,684,000 after purchasing an additional 142,723 shares during the period. Institutional investors and hedge funds own 80.41% of the company’s stock.
Insider Buying and Selling at Colgate-Palmolive
In other news, COO Panagiotis Tsourapas sold 19,938 shares of the company’s stock in a transaction on Wednesday, November 4th. The shares were sold at an average price of $98.74, for a total value of $1,968,678.12. Following the completion of the sale, the chief operating officer owned 9,111 shares in the company, valued at $899,620.14. This represents a 68.64% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Noel R. Wallace sold 20,000 shares of the company’s stock in a transaction on Thursday, November 5th. The stock was sold at an average price of $100.26, for a total transaction of $2,005,200.00. Following the completion of the sale, the chief executive officer owned 359,700 shares of the company’s stock, valued at approximately $36,063,522. The trade was a 5.27% decrease in their position. The SEC filing for this sale provides additional information. In the last three months, insiders have sold 73,314 shares of company stock worth $7,212,109. Corporate insiders own 0.43% of the company’s stock.
Analyst Ratings Changes
Several equities research analysts have weighed in on CL shares. Citigroup lifted their price target on shares of Colgate-Palmolive from $105.00 to $110.00 and gave the company a “buy” rating in a research note on Tuesday, July 14th. TD Cowen increased their price objective on shares of Colgate-Palmolive from $90.00 to $97.00 and gave the stock a “hold” rating in a research report on Monday, November 2nd. Weiss Ratings downgraded Colgate-Palmolive from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Friday, October 2nd. Raymond James Financial raised their target price on Colgate-Palmolive from $100.00 to $102.00 and gave the company an “outperform” rating in a research note on Monday, August 3rd. Finally, Wells Fargo & Company boosted their target price on Colgate-Palmolive from $90.00 to $95.00 and gave the company an “equal weight” rating in a research report on Monday, November 2nd. Thirteen research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $101.22.
Colgate-Palmolive Stock Performance
Shares of Colgate-Palmolive stock opened at $97.95 on Wednesday. The company has a market cap of $77.86 billion, a PE ratio of 38.41, a price-to-earnings-growth ratio of 4.43 and a beta of 0.31. Colgate-Palmolive Company has a 52 week low of $75.96 and a 52 week high of $101.18. The business has a 50 day moving average price of $90.42 and a 200-day moving average price of $90.10. The company has a quick ratio of 0.63, a current ratio of 0.96 and a debt-to-equity ratio of 11.23.
Colgate-Palmolive (NYSE:CL – Get Free Report) last announced its earnings results on Friday, October 30th. The company reported $0.97 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.93 by $0.04. The company had revenue of $5.37 billion for the quarter, compared to analysts’ expectations of $5.34 billion. Colgate-Palmolive had a return on equity of 607.88% and a net margin of 9.65%. Colgate-Palmolive’s quarterly revenue was up 4.6% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.91 earnings per share. Equities analysts anticipate that Colgate-Palmolive Company will post 3.92 earnings per share for the current fiscal year.
Colgate-Palmolive Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, November 13th. Investors of record on Tuesday, October 20th will be given a $0.53 dividend. This represents a $2.12 dividend on an annualized basis and a yield of 2.2%. The ex-dividend date of this dividend is Tuesday, October 20th. Colgate-Palmolive’s dividend payout ratio is presently 83.14%.
Colgate-Palmolive Profile
Colgate-Palmolive is a global consumer products company whose business spans oral care, personal care, home care and pet nutrition. Its products include toothpaste, toothbrushes, mouthwashes, soaps, shampoos, cleaning products and pet food. The company’s best-known brands include Colgate, Palmolive, elmex, Softsoap, Ajax and Hill’s Pet Nutrition. It sells products through retail and other channels in markets around the world. Founded in 1806 by William Colgate as a soap and candle business in New York City, the company has grown into an international manufacturer of household and personal care products.
Further Reading
- Five stocks we like better than Colgate-Palmolive
- Why Kinder Morgan’s Chairman Just Bought $15 Million in Stock
- Rocket Lab’s Record Backlog Could Fuel a Rebound, But Neutron Raises the Stakes
- Don’t Let Their Low Yields Fool You: 3 Dividend Stocks Worth Watching
- A $4 Billion Jolt: NRG Energy Powers Data Center Ambitions
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.
